CFDE Data Portal | Search MIR130AHG

	Label	Description
	MIR130AHG Gene (Entity type)	ENSG00000254602 - MIR130A host gene
	GSE162892 ISOX 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203267 ALKBH5 knockdown Ramia 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE130401 trametinib YAP 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE156761 dopamine neuron 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205976 GSE205978 CEP83 knockout TIME 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE212312 FBXW7 knockout Reh 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207376 GSE207377 nutlin-3 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

MIR130AHG

ENSG00000254602 - MIR130A host gene

GSE162892 ISOX 3 v 2 human dn

A Gene Set from LINCS

GSE203267 ALKBH5 knockdown Ramia 0 v 1 human dn

A Gene Set from LINCS

GSE130401 trametinib YAP 4 v 3 human dn

A Gene Set from LINCS

GSE156761 dopamine neuron 0 v 2 human up

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 4 human up

A Gene Set from LINCS

GSE205976 GSE205978 CEP83 knockout TIME 1 v 0 human dn

A Gene Set from LINCS

GSE212312 FBXW7 knockout Reh 2 v 0 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 10 human up

A Gene Set from LINCS

GSE207376 GSE207377 nutlin-3 3 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.